Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa

Author:

Zambonelli CarloORCID,Dey Antu K.,Hilt Susan,Stephenson Samuel,Go Eden P.,Clark Daniel F.,Wininger Mark,Labranche Celia,Montefiori David,Liao Hua-Xin,Swanstrom Ronald I.,Desaire Heather,Haynes Barton F.,Carfi Andrea,Barnett Susan W.

Funder

National Institute of Allergy and Infectious Diseases

Bill and Melinda Gates Foundation

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations;JH Van Harmelen;AIDS research and human retroviruses,1999

2. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004;J Hemelaar;Aids,2006

3. Access to essential medications for HIV/AIDS in South Africa;S Andrews;South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,2001

4. The impact of a partially effective HIV vaccine on a population of intravenous drug users in Bangkok, Thailand: a dynamic model;E Bogard;Journal of acquired immune deficiency syndromes,2002

5. Ending AIDS—is an HIV vaccine necessary?;AS Fauci;The New England journal of medicine,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3